105 related articles for article (PubMed ID: 30817682)
1. Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.
Zhao J; Liu B; Yang JA; Tang D; Wang X; Chen Q
Neuroreport; 2019 Apr; 30(6):446-451. PubMed ID: 30817682
[TBL] [Abstract][Full Text] [Related]
2. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.
Chen J; Zhang J; Hong L; Zhou Y
Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.
Guo RM; Zhao CB; Li P; Zhang L; Zang SH; Yang B
ASN Neuro; 2018; 10():1759091418781949. PubMed ID: 29914265
[TBL] [Abstract][Full Text] [Related]
4. Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.
Chen L; Su G
Biomed Res Int; 2019; 2019():2582416. PubMed ID: 31183364
[TBL] [Abstract][Full Text] [Related]
5. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
6. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
7. Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma.
Shoji K; Murayama T; Mimura I; Wada T; Kume H; Goto A; Ohse T; Tanaka T; Inagi R; van der Hoorn FA; Manabe I; Homma Y; Fukayama M; Sakurai T; Hasegawa T; Aburatani H; Kodama T; Nangaku M
Am J Pathol; 2013 Jun; 182(6):2191-203. PubMed ID: 23602831
[TBL] [Abstract][Full Text] [Related]
8. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
9. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme.
Bien-Möller S; Lange S; Holm T; Böhm A; Paland H; Küpper J; Herzog S; Weitmann K; Havemann C; Vogelgesang S; Marx S; Hoffmann W; Schroeder HW; Rauch BH
Oncotarget; 2016 Mar; 7(11):13031-46. PubMed ID: 26887055
[TBL] [Abstract][Full Text] [Related]
10. Sperm‑associated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.
Ji Y; Jiang J; Huang L; Feng W; Zhang Z; Jin L; Xing X
Oncol Rep; 2018 Aug; 40(2):783-792. PubMed ID: 29901114
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
12. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
Cheng P; Ma Y; Gao Z; Duan L
Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
[TBL] [Abstract][Full Text] [Related]
13. Homeobox B2 is a potential prognostic biomarker of glioblastoma.
Li M; Wang JF; Liu B; Wang XM
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):794-799. PubMed ID: 32696872
[TBL] [Abstract][Full Text] [Related]
14. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
16. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
[TBL] [Abstract][Full Text] [Related]
17. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.
Liu B; Liu J; Liao Y; Jin C; Zhang Z; Zhao J; Liu K; Huang H; Cao H; Cheng Q
Med Sci Monit; 2019 May; 25():3624-3635. PubMed ID: 31094363
[TBL] [Abstract][Full Text] [Related]
18. Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.
Zhang L; Wang G; Chen S; Ding J; Ju S; Cao H; Tian H
World J Surg Oncol; 2016 Oct; 14(1):267. PubMed ID: 27756319
[TBL] [Abstract][Full Text] [Related]
19. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
20. Epilysin is overexpressed in glioblastoma and related to clinical outcome of patients.
Wang X; Zhang K; Chen X; Zhao C; Sun Z
Med Oncol; 2015 Jan; 32(1):363. PubMed ID: 25429835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
